Uddannelse
1991:
cand. psych., Psykologisk Institut, Aarhus Universitet
1995:
ph.d. (behavioural neuroscience), Institut for Medicinsk Biologi, Odense Universitet
1994-1997:
post doc (adfærdsfarmakologi), Novo Nordisk A/S.
2006:
cand. psych. aut.
Ansættelser
1989-1990:
Skolarstipendiat, Neurobiologisk Institut, Aarhus Universitet
1991-1994:
Kandidatstipendiat (Forskerakademiet), Institut for Medicinsk Biologi, Odense Universitet
1994-1997:
Post doc, Behavioral Pharmacology, Novo Nordisk A/S
1998-2000:
Clinical developmental scientist, Nycomed A/S
2000-2003:
Amanuensis, Institut for Psykologi; forskningsassistent, Institut for Medicinsk Biokemi og Genetik, Panuminstituttet, Københavns Universitet.
2003-2005:
Neuropsykolog, Center for Hjerneskade
2005-2006:
Neuropsykolog, Esbønderup Sygehus
2007-2011:
Neuropsykolog, Neurologisk Afdeling, Hillerød Hospital
2011-2012:
Psykolog, ADHD-ambulatoriet Psykiatrisk Center Glostrup
Selvstændig praksis
2005:
-
Publikationer
1. Rasmussen T (1996) Aged rats impaired of spatial memory: Evaluation with the Morris' Watermaze and estimation of the total number of neurons in 5 subdivisions of the hippocampal region using the optical fractionator. Disser Abstr Int 57(5)
2. Rasmussen T, Schliemann T, Sørensen JC, Zimmer J, West MJ (1996) Memory impaired aged rats: no loss of principal hippocampal and subicular neurons. Neurobiol Aging 17(1):143-7.
3. Olesen PH, Swedberg MDB, Eskesen K, Judge ME, Egebjerg J, Tønder JE, Rasmussen T, Sheardown MJ, Rimvall K (1997) Identification of novel (isoxazole)methylene-1-azabicyclic compounds with high affinity for the central nicotinic cholinergic receptor. Biorg Med Chem Letters 7(15):1963-8.
4. Sauerberg P, Jeppesen L, Olesen PH, Rasmussen T, Swedberg MDB, Sheardown MJ, Fink-Jensen A, Thomsen C, Thøgersen H, Rimvall K, Ward JS, Calligaro DO, DeLapp NW, Bymaster FP, Shannon HE (1998) Muscarinic agonists with antipsychotic-like activity: Structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity. J Med Chem 41(22):4378-84.
5. Sauerberg P, Jeppesen L, Olesen PH, Sheardown MJ, Fink-Jensen A, Rasmussen T, Rimvall K, Shannon HE, Bymaster FP, DeLapp NW, Calligaro DO, Ward JS, Whitesitt CA, Thomsen C (1998) Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic M1 receptor activation Bioorg Med Chem Lett 8:2897-902.
6. Aznar S, Rasmussen T, Zimmer J (1998) Impaired learning correlates with size of excitotoxic hippocampal CA3 lesions in adult rats, but shows no amelioration by CA3 transplants. Restor Neurol Neurosci 13:141-51.
7. Rasmussen T, Swedberg MDB (1998) Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 60(2):567-73.
8. Fink-Jensen A, Kristensen P, Shannon HE, Calligaro DO, DeLapp NW, Whitesitt C, Ward JS, Thomsen C, Rasmussen T, Sheardown MJ, Jeppesen L, Sauerberg P, Bymaster FP (1998) Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats. NeuroReport 9:3481-6.
9. Bymaster FP, Shannon HE, Rasmussen K, DeLapp NW, Ward JS, Calligaro DO, Mitch CH, Whitesitt C, Ludvigsen TS, Sheardown M, Swedberg M, Rasmussen T, Olesen PH, Jeppesen L, Sauerberg P, Fink-Jensen A (1999) Potential role of muscarinic receptors in schizophrenia. Life Sci 64(6-7):527-34.
10. Jeppesen L, Olesen PH, Hansen L, Sheardown MJ, Thomsen C, Rasmussen T, Fink-Jensen A, Christensen MS, Rimvall K, Ward JS, Whitesitt C, Calligaro DO, Bymaster FP, DeLapp NW, Felder C, Shannon HE, Sauerberg P (1999) 1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0.2,6]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivates. J Med Chem 42(11):1999-2006.
11. Rasmussen T, Fink-Jensen A (2000) Intravenous scopolamine is potently self-administered in drug-naive mice. Neuropsychopharmacology 22(1):97-99
12. Rasmussen T, Sauerberg P, Nielsen EB, Swedberg MDB, Thomsen C, Sheardown MJ, Jeppesen L, Calligaro DO, DeLapp NW, Whitesitt C, Ward JS, Shannon HE, Bymaster FP, Fink-Jensen A (2000) Muscarinic agonists decrease cocaine self-administration rates in drug-naive mice. Eur J Pharmacol 402:241-6.
13. Rasmussen T, Fink-Jensen A, Sauerberg P, Swedberg MDB, Thomsen C, Sheardown MJ, Jeppesen L, Calligaro DO, DeLapp NW, Whitesitt C, Ward JS, Shannon HE, Bymaster FP (2001) The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance. Schizophr Res 49(1-2):193-201
14. Fink-Jensen A, Fedorova I, Wörtwein G, Woldbye DPD, Rasmussen T, Thomsen M, Bolwig TG, Knitowski KM, McKinzie DL, Yamada M, Wess J, Basile A (2003) Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 74(1):91-96

Undervisnings- og vejledningserfaring

  • Underviser på en hoben postgraduate kurser ved Det Sundhedsvidenskabelige Fakultet, Odense Universitet; Det Sundhedsvidenskabelige Fakultet, Aarhus Universitet; samt Danmarks Farmaceutiske Højskole.
  • Amanuensis i kognitions- og indlæringspsykologi 2000-2003 ved Institut for Psykologi, Københavns Universitet.
  • Underviser ved Folkeuniversitetet, København 2001-2003.
  • Diverse intern undervisning ved Nordsjællands Hospital.
  • Opgave- og specialevejledninger ved Institut for Psykologi, Københavns Universitet; Institut for Medicinsk Biokemi og genetik, Københavns Universitet; samt institut for Medicinsk Biologi, Odense Universitet.
  • Supervision af psykologer mhp. opnåelse af autorisation (cand. psych. aut.) fra Socialministeriet
loading